{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:11:37Z","timestamp":1792681897648,"version":"4.5.0"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Primary tumor (PT) and metastatic cervical lymph node (LN) characteristics are highly associated with oropharyngeal squamous cell carcinoma (OPSCC) prognosis. Currently, there is a lack of studies to combine imaging characteristics of both regions for predictions of p16+ OPSCC outcomes.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To develop and validate a computed tomography (CT)\u2013based deep learning classifier that integrates PT and LN features to predict outcomes in p16+ OPSCC and to identify patients with stage I disease who may derive added benefit associated with chemotherapy.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this retrospective prognostic study, radiographic CT scans were analyzed of 811 patients with p16+ OPSCC treated with definitive radiotherapy or chemoradiotherapy from 3 independent cohorts. One cohort from the Cancer Imaging Archive (1998-2013) was used for model development and validation and the 2 remaining cohorts (2002-2015) were used to externally test the model performance. The Swin Transformer architecture was applied to fuse the features from both PT and LN into a multiregion imaging risk score (SwinScore) to predict survival outcomes across and within subpopulations at various stages. Data analysis was performed between February and July 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Definitive radiotherapy or chemoradiotherapy treatment for patients with p16+ OPSCC.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Hazard ratios (HRs), log-rank tests, concordance index (C index), and net benefit were used to evaluate the associations between multiregion imaging risk score and disease-free survival (DFS), overall survival (OS), and locoregional failure (LRF). Interaction tests were conducted to assess whether the association of chemotherapy with outcome significantly differs across dichotomized multiregion imaging risk score subgroups.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The total patient cohort comprised 811 patients with p16+ OPSCC (median age, 59.0 years [IQR, 47.4-70.6 years]; 683 men [84.2%]). In the external test set, the multiregion imaging risk score was found to be prognostic of DFS (HR, 3.76 [95% CI, 1.99-7.10];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), OS (HR, 4.80 [95% CI, 2.22-10.40];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and LRF (HR, 4.47 [95% CI, 1.43-14.00];\n P<\/jats:italic>\n \u2009=\u2009.01) among all patients with p16+ OPSCC. The multiregion imaging risk score, integrating both PT and LN information, demonstrated a higher C index (0.63) compared with models focusing solely on PT (0.61) or LN (0.58). Chemotherapy was associated with improved DFS only among patients with high scores (HR, 0.09 [95% CI, 0.02-0.47];\n P<\/jats:italic>\n \u2009=\u2009.004) but not those with low scores (HR, 0.83 [95% CI, 0.32-2.10];\n P<\/jats:italic>\n \u2009=\u2009.69).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This prognostic study of p16+ OPSCC describes the development of a CT-based imaging risk score integrating PT and metastatic cervical LN features to predict recurrence risk and identify suitable candidates for treatment tailoring. This tool could optimize treatment modulations of p16+ OPSCC at a highly granular level.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.8094","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:31:00Z","timestamp":1746099060000},"page":"e258094","source":"Crossref","is-referenced-by-count":14,"title":["Deep Learning Model of Primary Tumor and Metastatic Cervical Lymph Nodes From CT for Outcome Predictions in Oropharyngeal Cancer"],"prefix":"10.1001","volume":"8","author":[{"given":"Bolin","family":"Song","sequence":"first","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Leroy","sequence":"additional","affiliation":[{"name":"Therapanacea, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa Neuroscience Institute, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirvan","family":"Khalighi","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krunal","family":"Pandav","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Dam","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lee","sequence":"additional","affiliation":[{"name":"Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stock","sequence":"additional","affiliation":[{"name":"Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao T.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Sonuga","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Koyfman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa Neuroscience Institute, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil F.","family":"Saba","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Winship Cancer Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Madabhushi","sequence":"additional","affiliation":[{"name":"Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia"},{"name":"Atlanta Veterans Affairs Medical Center, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"issue":"11","key":"zoi250299r1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jamaoto.2023.1944","article-title":"Differences in functional and survival outcomes between patients receiving primary surgery vs chemoradiation therapy for treatment of T1-T2 oropharyngeal squamous cell carcinoma.","volume":"149","author":"Amin","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"18","key":"zoi250299r2","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1200\/JCO.19.00441","article-title":"Role of treatment deintensification in the management of p16+ oropharyngeal cancer: ASCO provisional clinical opinion.","volume":"37","author":"Adelstein","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"zoi250299r3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002).","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi250299r4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cancers15071959","article-title":"Novel immunotherapeutic approaches to treating HPV-related head and neck cancer.","volume":"15","author":"Saba","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"zoi250299r5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/jamaoto.2016.3353","article-title":"The role of adjuvant chemotherapy in surgically managed, p16-positive oropharyngeal squamous cell carcinoma.","volume":"143","author":"Skillington","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"zoi250299r6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3389\/fonc.2019.00936","article-title":"Deintensification of adjuvant treatment after transoral surgery in patients with human papillomavirus\u2013positive oropharyngeal cancer: the conception of the PATHOS study and its development.","volume":"9","author":"Hargreaves","year":"2019","journal-title":"Front Oncol"},{"issue":"29","key":"zoi250299r7","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus\u2013associated oropharyngeal squamous cell carcinoma.","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi250299r8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/oncolo\/oyab001","article-title":"Comparison of the seventh and eighth edition of American Joint Committee on Cancer (AJCC) Staging for selected and nonselected oropharyngeal squamous cell carcinomas.","volume":"27","author":"Vijayvargiya","year":"2022","journal-title":"Oncologist"},{"issue":"5","key":"zoi250299r9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"zoi250299r10","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00405-020-05979-9","article-title":"A review of the 8th edition of the AJCC staging system for oropharyngeal cancer according to HPV status.","volume":"277","author":"Machczynski","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"zoi250299r11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/s12885-019-5894-8","article-title":"Validation of the 8th edition UICC\/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy.","volume":"19","author":"van Gysen","year":"2019","journal-title":"BMC Cancer"},{"key":"zoi250299r12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.","volume":"144","author":"Huang","year":"2020","journal-title":"Radiother Oncol"},{"issue":"11","key":"zoi250299r13","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1002\/hed.25927","article-title":"The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma.","volume":"41","author":"Xiao","year":"2019","journal-title":"Head Neck"},{"issue":"3","key":"zoi250299r14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2967\/jnumed.113.125542","article-title":"PET\/CT imaging and human papilloma virus\u2013positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.","volume":"55","author":"Subramaniam","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"zoi250299r15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41698-023-00404-w","article-title":"CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma.","volume":"7","author":"Song","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"7","key":"zoi250299r16","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/cancers12071778","article-title":"Potential added value of PET\/CT radiomics for survival prognostication beyond AJCC 8th edition staging in oropharyngeal squamous cell carcinoma.","volume":"12","author":"Haider","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"zoi250299r17","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1097\/JS9.0000000000001578","article-title":"MRI-based deep learning and radiomics for prediction of occult cervical lymph node metastasis and prognosis in early-stage oral and oropharyngeal squamous cell carcinoma: a diagnostic study.","volume":"110","author":"Lan","year":"2024","journal-title":"Int J Surg"},{"issue":"14","key":"zoi250299r18","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1158\/1078-0432.CCR-20-4935","article-title":"Deep learning for fully automated prediction of overall survival in patients with oropharyngeal cancer using FDG-PET imaging.","volume":"27","author":"Cheng","year":"2021","journal-title":"Clin Cancer Res"},{"key":"zoi250299r19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.744250","article-title":"Radiomic features associated with HPV status on pretreatment computed tomography in oropharyngeal squamous cell carcinoma inform clinical prognosis.","volume":"11","author":"Song","year":"2021","journal-title":"Front Oncol"},{"issue":"10","key":"zoi250299r20","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.1002\/mp.16465","article-title":"CT-based deep multi-label learning prediction model for outcome in patients with oropharyngeal squamous cell carcinoma.","volume":"50","author":"Ma","year":"2023","journal-title":"Med Phys"},{"key":"zoi250299r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.107939","article-title":"Deep learning\u2013based outcome prediction using PET\/CT and automatically predicted probability maps of primary tumor in patients with oropharyngeal cancer.","volume":"244","author":"De Biase","year":"2024","journal-title":"Comput Methods Programs Biomed"},{"issue":"4","key":"zoi250299r22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ijrobp.2019.03.036","article-title":"Integrating tumor and nodal imaging characteristics at baseline and mid-treatment computed tomography scans to predict distant metastasis in oropharyngeal cancer treated with concurrent chemoradiotherapy.","volume":"104","author":"Wu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"zoi250299r25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ijrobp.2018.01.057","article-title":"Radiomic biomarkers to refine risk models for distant metastasis in HPV-related oropharyngeal carcinoma.","volume":"102","author":"Kwan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"zoi250299r26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","article-title":"The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository.","volume":"26","author":"Clark","year":"2013","journal-title":"J Digit Imaging"},{"key":"zoi250299r30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"issue":"9","key":"zoi250299r31","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network.","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"3\/4","key":"zoi250299r33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2307\/2332579","article-title":"On the comparison of several mean values: an alternative approach.","volume":"38","author":"Welch","year":"1951","journal-title":"Biometrika"},{"issue":"3","key":"zoi250299r34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1214\/aoms\/1177729380","article-title":"The ?2 test of goodness of fit.","volume":"23","author":"Cochran","year":"1952","journal-title":"Ann Math Stat"},{"issue":"3","key":"zoi250299r35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/bimj.200800228","article-title":"The concordance index C and the Mann-Whitney parameter Pr(X>Y) with randomly censored data.","volume":"51","author":"Koziol","year":"2009","journal-title":"Biom J"},{"issue":"1","key":"zoi250299r36","doi-asserted-by":"publisher","first-page":"c83","DOI":"10.1159\/000324758","article-title":"Survival analysis I: the Kaplan-Meier method.","volume":"119","author":"Stel","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"10","key":"zoi250299r40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/03610928008827941","article-title":"Goodness of fit tests for the multiple logistic regression model.","volume":"9","author":"Hosmer","year":"1980","journal-title":"Commun Stat Theory Methods"},{"issue":"6","key":"zoi250299r41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models.","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"zoi250299r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110368","article-title":"PET\/CT based transformer model for multi-outcome prediction in oropharyngeal cancer.","volume":"197","author":"Ma","year":"2024","journal-title":"Radiother Oncol"},{"issue":"4","key":"zoi250299r44","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1109\/TMI.2020.3021387","article-title":"Pathomic fusion: an integrated framework for fusing histopathology and genomic features for cancer diagnosis and prognosis.","volume":"41","author":"Chen","year":"2022","journal-title":"IEEE Trans Med Imaging"},{"issue":"12","key":"zoi250299r45","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s00405-018-5156-4","article-title":"The 8th edition AJCC\/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?","volume":"275","author":"Sharma","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"24","key":"zoi250299r46","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1200\/JCO.21.00594","article-title":"Treatment de-intensification for HPV-positive oropharynx cancer: what is currently acceptable?","volume":"39","author":"Cmelak","year":"2021","journal-title":"J Clin Oncol"},{"issue":"32","key":"zoi250299r47","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States.","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"29","key":"zoi250299r48","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus\u2013positive head and neck squamous cell carcinoma.","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi250299r49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"issue":"21","key":"zoi250299r50","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.","volume":"26","author":"Machtay","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi250299r51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311).","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"40","key":"zoi250299r52","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41388-023-02819-y","article-title":"Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer.","volume":"42","author":"Lim","year":"2023","journal-title":"Oncogene"},{"issue":"25","key":"zoi250299r53","doi-asserted-by":"publisher","first-page":"11707","DOI":"10.7150\/thno.50565","article-title":"Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"zoi250299r54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100906","article-title":"Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET\/CT radiomics.","volume":"14","author":"Haider","year":"2021","journal-title":"Transl Oncol"},{"issue":"6","key":"zoi250299r55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s43018-022-00388-9","article-title":"Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.","volume":"3","author":"Boehm","year":"2022","journal-title":"Nat Cancer"},{"key":"zoi250299r56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104373","article-title":"Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.","volume":"86","author":"Zeng","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"zoi250299r57","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41379-022-01024-8","article-title":"Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.","volume":"35","author":"Wilde","year":"2022","journal-title":"Mod Pathol"},{"key":"zoi250299r58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102805","article-title":"A prognostic gene expression signature for oropharyngeal squamous cell carcinoma.","volume":"61","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"6","key":"zoi250299r59","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/jnci\/djaa161","article-title":"A MicroRNA expression signature as prognostic marker for oropharyngeal squamous cell carcinoma.","volume":"113","author":"Liu","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"zoi250299r23","author":"Liu"},{"key":"zoi250299r39","author":"Sundararajan"},{"key":"zoi250299r24","unstructured":"Vaswani? A, Shazeer? N, Parmar? N, . Attention is all you need.? arXiv. Preprint posted online June 12, 2017. Last revised August 2, 2023. doi:10.48550\/arXiv.1706.03762"},{"key":"zoi250299r27","unstructured":"Grossberg? A, Elhalawani? H, Mohamed? A, ; M.D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group. HNSCC version 4 [dataset]. The Cancer Imaging Archive. 2020. Accessed March 20, 2025. https:\/\/doi.org\/10.7937\/k9\/tcia.2020.a8sh-7363"},{"key":"zoi250299r28","unstructured":"Valli\u00e8res? M, Kay-Rivest? E, Perrin? LJ, . Data from Head-Neck-PET-CT. The Cancer Imaging Archive. 2017. Accessed March 20, 2025. https:\/\/doi.org\/10.7937\/K9\/TCIA.2017.8oje5q00"},{"key":"zoi250299r29","unstructured":"Wee? L, Dekker? A. Data from HEAD-NECK-RADIOMICS-HN1 [data set]. The Cancer Imaging Archive. 2019. Accessed March 20, 2025. https:\/\/www.cancerimagingarchive.net\/collection\/head-neck-radiomics-hn1\/"},{"key":"zoi250299r32","unstructured":"Tops\u00f8e? F. Bounds for entropy and divergence for distributions over a two-element set. JIPAM J Inequalities Pure Appl Math. 2001;2(2):Paper No. 25, 13 p. Accessed March 20, 2025. https:\/\/eudml.org\/doc\/122035"},{"key":"zoi250299r37","doi-asserted-by":"crossref","unstructured":"Harrington? D. Linear rank tests in survival analysis. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. 2nd ed. John Wiley & Sons, Ltd; 2005. Accessed June 17, 2024. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/0470011815.b2a11047","DOI":"10.1002\/0470011815.b2a11047"},{"key":"zoi250299r38","unstructured":"Lundberg? S, Lee? SI. A unified approach to interpreting model predictions.? arXiv. Preprint posted online May 22, 2017. Last revised November 25, 2017. doi:10.48550\/arXiv.1705.07874"},{"key":"zoi250299r42","unstructured":"R: a Language and Environment for Statistical Computing. February 10, 2015. Accessed June 17, 2024. https:\/\/www.gbif.org\/tool\/81287\/r-a-language-and-environment-for-statistical-computing"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2833354\/song_2025_oi_250299_1745349640.65412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:31:04Z","timestamp":1746099064000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2833354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.8094","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}